Cast of Characters: Jay Inslee, Governor, Washington | Gavin Newsom, Governor, California | Doug Ducey, Governor, Arizona |…
On Jun. 22, 2021, BioReference Laboratories, an OPKO Health company, announced a COVID-19 testing program for U.S. based…
On Oct. 6, 2021, the World Health Organization and its COVAX partners are working with a South African…
On Jun. 1, 2021, a study by researchers at the National Institutes of Health and their colleagues found…
On May 27, 2021, Sanofi and GlaxoSmithKline started enrolment in their Phase 3 clinical study to assess the…
On May 18, 2021, National Resilience announced that the Government of Canada will invest CAD 199.2 million ($163.8…
On May 12, 2021, Inovio Pharma announced that its next-generation Pan-COVID-19 vaccine candidate, INO-4802, induced potent neutralizing antibodies…
On May 10, 2021, Pfizer and BioNTech announced that the U.S. Food and Drug Administration (FDA) had expanded…
On May 7, 2021, GlaxoSmithKline and Vir Biotechnology announced that the European Medicines Agency (EMA) has started a…
On Apr. 30, 2021, the FDA approved AstraZeneca’s Farxiga (dapagliflozin) oral tablets to reduce the risk of kidney…
On Apr. 30, 2021, the FDA revoked the emergency use authorization (EUA) of the Battelle CCDS Critical Care…
On Apr. 29, 2021, researchers at the University of British Columbia (UBC) announced a study published in Cell…
On Apr. 28, 2021, HHMI investigator Erich Jarvis and dozens of colleagues announced they had launched an ambitious…
On Apr. 28, 2021, XPhyto announce that it has delivered 2,000 of its rapid 25-minute PCR tests (ﾓCovid-ID…
On Apr. 28, 2021, VBI Vaccines announced that preclinical data of VBIﾒs enveloped virus-like particle (eVLP) vaccine candidate,…
On Apr. 28, 2021, Innovation Pharma announced that enrollment had surpassed 50 percent of the total targeted number…
On Apr. 27, 2021, Merck announced the company had entered into non-exclusive voluntary licensing agreements for molnupiravir with…
On Apr. 27, 2021, AIM ImmunoTech announced that it had completed dosing of Cohort 2 in a Phase…
On Apr. 26, 2021, Gilead Sciences announced that in response to the rapid increase in COVID-19 cases in…
On Apr. 23, 2021, the NIH announced that a study assessing how people with immune system deficiencies or…
On Apr. 23, 2021, following a thorough safety review, including two meetings of the CDCﾒs Advisory Committee on…
On Apr. 22, 2021, the NIH announced that a phase 3 trial to test the safety and efficacy…
On Apr. 22, 2021, RELIEF THERAPEUTICS and AdVita Lifescience announced that the first patient was expected to be…
On Apr. 22, 2021, the Strategic Advisory Group of Experts (SAGE) on Immunization annouced updated interim guidance on…
On Apr. 22, 2021, Quidel announced that it had completed a distribution and fulfillment agreement with McKesson to…
On Apr. 21, 2021, XPhyto announced that it had entered into an agreement with an established German pharmaceutical…
On Apr. 21, 2021, Dynavax Technologies announced Valneva had initiated a pivotal Phase 3 clinical trial for its…
On Apr. 21, 2021,Trevena announced that TRV027, the Companyﾒs novel AT1 receptor selective agonist, had been selected for…
On Apr. 21, 2021, the FDA announced that it had completed an inspection of the Emergent BioSolutions and…
On Apr. 20, 2021, the University of Oxford, Prenetics, and Oxford Suzhou Centre for Advanced Research announced that…